Revvity Inc (RVTY) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jul 05 2026 to Jun 29 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Revvity Inc  (NYSE: RVTY)

Revvity Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Revvity Inc in the second quarter 2026?
Revvity Inc achieved a return on average equity (ROE) of 3.27 % in its second quarter 2026, which is below Revvity Inc's average return on equity, which stands at 9.3%.

ROE has advanced compared to 3.26% in the first quarter 2026, due to net income growth.

Within the Laboratory Analytical Instruments industry 4 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 2072 to 2114.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jul 05 2026)
II. Quarter		 (Apr 05 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter		 (Jun 29 2025)
II. Quarter
Y / Y Equity Change -4.33 % -5.95 % -5.43 % -6.89 % -
Y / Y Net Income Change -3.94 % -3.6 % 3.93 % -50.56 % -2.55 %
Net Income (TTM) in Millions 238 240 241 237 285
Return On Equity (TTM) 3.27 % 3.26 % 3.24 % 3.14 % 3.71 %
RVTY's Total Ranking # 2114 # 2072 # 1861 # 1485 # 1747
Equity (TTM) in Millions 7,229 7,183 7,250 7,376 7,556
Seq. Equity Change 0.64 % -0.93 % -1.7 % -2.39 % -1.06 %
Seq. Net Income Change 27.27 % -58.6 % 110.85 % -13.52 % 27.73 %

Back to RVTY Management Effectiveness >> RVTY's 5 Years Annual ROE >> Compare RVTY ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 5
Sector # 173
Overall # 2114

Return On Equity Statistics
High Average Low
31.09 %
9.3 %
-1.99 %
(Jul 04 2021)   (Mar 31 2013)



  News about Revvity Inc Return on Equity ROE

Revvity Secures Masterminds of AI and Business Innovation to Revitalize Board of Directors

Revvity Strengthens its Board of Directors with Distinguished Appointments
WALTHAM, Mass. - In a move aimed at bolstering its leadership and advancing its strategic goals, Revvity, Inc. (NYSE: RVTY) announced today the election of Sophie Vandebroek and Michael Klobuchar to its board of directors, effective February 1, 2024. This latest development comes as the company seeks to capitalize on emerging trends and position itself for future growth.
With these high-profile appointments, Revvity demonstrates its commitment to assembling a dynamic team of leaders with diverse expertise. Sophie Vandebroek, a distinguished executive renowned for her pioneering work in various fields, brings an unparalleled depth of knowledge in AI, business processes, sustainability, and cybersecurity. Her invaluable insights and rich experience will undoubtedly contribute to Revvity s strategic vision and shape the company s path to success.



RVTY Annual Return On Equity (Dec 28 2025)
2025		 (Dec 29 2024)
2024		 (Dec 31 2023)
2023		 (Jan 01 2023)
2022		 (Jan 02 2022)
2021
Total Equity in Millions 7,250 7,667 7,873 7,383 7,065
Y / Y Equity Change -5.43 % -2.61 % 6.64 % 4.5 % 89.14 %
Net Income in Millions 241 270 693 569 943
Y / Y Net Income Change -10.79 % -60.99 % 21.77 % -39.65 % 29.57 %
Return On Equity 3.33 % 3.53 % 8.8 % 7.71 % 13.35 %

Back to RVTY Management Effectiveness >> RVTY's 5 Years Annual ROE >> Compare RVTY ROE to its Competitors




Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 3.33 %, due to deterioration of net income.


More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RVTY's' Return on Equity at Yahoo Finance
RVTY's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RVTY's Competitors
Subscribers only: Roe for Revvity Inc's Suppliers
Subscribers only: Return On Equity for RVTY's Customers




Companies with similar Return On Equity at Jul 05 2026, within Healthcare Sector ROE
Utah Medical Products Inc  8.74 %
Vaso Corporation  8.65 %
Veracyte Inc   8.64 %
Corcept Therapeutics Inc  8.27 %
Integer Holdings Corporation  7.43 %
Pacific Health Care Organization Inc  7.42 %
Vericel Corporation  6.91 %
The Cooper Companies Inc   6.90 %
Siga Technologies Inc  6.74 %
Merck and Co Inc   6.59 %
Zimmer Biomet Holdings Inc   6.36 %
National Vision Holdings Inc   5.71 %
Conmed Corporation  5.51 %
Pfizer Inc  4.91 %
Privia Health Group Inc   4.23 %
Becton Dickinson And Company  3.79 %
Alkermes Plc   3.72 %
Lifemd Inc   3.47 %
Lifestance Health Group Inc   3.39 %
Revvity Inc  3.27 %
Bio rad Laboratories Inc   3.15 %
Envista Holdings Corporation  3.08 %
Immucell Corporation  2.68 %
Surgery Partners Inc   2.63 %
Mimedx Group Inc   2.61 %
Cormedix Inc   2.18 %
Atricure Inc   2.14 %
Pacira Biosciences inc   2.13 %
Warby Parker Inc   2.06 %
Repligen Corp  1.98 %

Date modified: 2026-09-26T07:19:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.